GLAND PHARMA
|
GLAND PHARMA Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr | ₹2,633 Cr |
| Sales | ₹4,078 Cr | ₹3,272 Cr | ₹3,970 Cr | ₹3,131 Cr | ₹2,322 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹1,564 Cr | ₹319 Cr | ₹414 Cr | ₹292 Cr | ₹250 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹23 Cr | ₹33 Cr | ₹17 Cr | ₹39 Cr | ₹61 Cr |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹5,665 Cr | ₹3,625 Cr | ₹4,401 Cr | ₹3,463 Cr | ₹2,633 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹128 Cr | ₹-47 Cr | ₹37 Cr | ₹-273 Cr | ₹-6.90 Cr |
| Raw Material Consumed | ₹2,045 Cr | ₹1,732 Cr | ₹2,073 Cr | ₹1,492 Cr | ₹843 Cr |
| Opening Raw Materials | ₹979 Cr | ₹466 Cr | ₹530 Cr | ₹302 Cr | ₹428 Cr |
| Purchases Raw Materials | ₹1,502 Cr | ₹2,230 Cr | ₹1,983 Cr | ₹1,704 Cr | ₹699 Cr |
| Closing Raw Materials | ₹459 Cr | ₹979 Cr | ₹466 Cr | ₹530 Cr | ₹302 Cr |
| Other Direct Purchases / Brought in cost | ₹23 Cr | ₹16 Cr | ₹26 Cr | ₹16 Cr | ₹19 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹230 Cr | ₹125 Cr | ₹95 Cr | ₹75 Cr | ₹79 Cr |
| Electricity & Power | ₹230 Cr | ₹125 Cr | ₹95 Cr | ₹75 Cr | ₹79 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹1,257 Cr | ₹403 Cr | ₹339 Cr | ₹311 Cr | ₹278 Cr |
| Salaries, Wages & Bonus | ₹955 Cr | ₹363 Cr | ₹300 Cr | ₹260 Cr | ₹238 Cr |
| Contributions to EPF & Pension Funds | ₹252 Cr | ₹16 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr |
| Workmen and Staff Welfare Expenses | ₹40 Cr | ₹18 Cr | ₹15 Cr | ₹20 Cr | ₹8.91 Cr |
| Other Employees Cost | ₹10 Cr | ₹6.70 Cr | ₹11 Cr | ₹21 Cr | ₹20 Cr |
| Other Manufacturing Expenses | ₹327 Cr | ₹194 Cr | ₹180 Cr | ₹437 Cr | ₹392 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹151 Cr | ₹49 Cr | ₹45 Cr | ₹42 Cr | ₹34 Cr |
| Packing Material Consumed | - | - | - | ₹273 Cr | ₹266 Cr |
| Other Mfg Exp | ₹176 Cr | ₹145 Cr | ₹135 Cr | ₹122 Cr | ₹92 Cr |
| General and Administration Expenses | ₹217 Cr | ₹121 Cr | ₹94 Cr | ₹59 Cr | ₹58 Cr |
| Rent , Rates & Taxes | ₹71 Cr | ₹65 Cr | ₹59 Cr | ₹38 Cr | ₹38 Cr |
| Insurance | ₹29 Cr | ₹11 Cr | ₹9.88 Cr | ₹6.37 Cr | ₹2.93 Cr |
| Printing and stationery | ₹4.09 Cr | ₹3.15 Cr | ₹3.29 Cr | ₹2.90 Cr | ₹2.45 Cr |
| Professional and legal fees | ₹94 Cr | ₹36 Cr | ₹19 Cr | ₹7.87 Cr | ₹9.12 Cr |
| Traveling and conveyance | ₹9.57 Cr | ₹3.85 Cr | ₹1.84 Cr | ₹1.39 Cr | ₹3.11 Cr |
| Other Administration | ₹9.10 Cr | ₹1.32 Cr | ₹1.28 Cr | ₹2.23 Cr | ₹2.27 Cr |
| Selling and Distribution Expenses | ₹37 Cr | ₹27 Cr | ₹41 Cr | ₹37 Cr | ₹17 Cr |
| Advertisement & Sales Promotion | ₹4.61 Cr | ₹4.56 Cr | ₹2.02 Cr | ₹1.95 Cr | ₹5.19 Cr |
| Sales Commissions & Incentives | ₹14 Cr | ₹2.76 Cr | ₹3.88 Cr | ₹1.77 Cr | ₹1.45 Cr |
| Freight and Forwarding | ₹19 Cr | ₹20 Cr | ₹35 Cr | ₹33 Cr | ₹10 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹90 Cr | ₹45 Cr | ₹33 Cr | ₹24 Cr | ₹19 Cr |
| Bad debts /advances written off | ₹7.59 Cr | ₹2.20 Cr | ₹0.34 Cr | ₹0.28 Cr | ₹1.62 Cr |
| Provision for doubtful debts | ₹14 Cr | - | ₹3.79 Cr | ₹0.12 Cr | ₹4.32 Cr |
| Losson disposal of fixed assets(net) | - | ₹0.08 Cr | ₹0.18 Cr | - | - |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹68 Cr | ₹42 Cr | ₹28 Cr | ₹23 Cr | ₹13 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr | ₹1,678 Cr |
| Operating Profit (Excl OI) | ₹1,333 Cr | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr | ₹955 Cr |
| Other Income | ₹170 Cr | ₹240 Cr | ₹224 Cr | ₹135 Cr | ₹139 Cr |
| Interest Received | ₹151 Cr | ₹179 Cr | ₹139 Cr | ₹86 Cr | ₹51 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | ₹0.25 Cr | - | - | ₹0.02 Cr | ₹17 Cr |
| Profits on sale of Investments | ₹0.35 Cr | ₹2.85 Cr | - | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | ₹11 Cr | ₹57 Cr | ₹79 Cr | ₹41 Cr | ₹69 Cr |
| Others | ₹8.43 Cr | ₹1.05 Cr | ₹6.09 Cr | ₹8.28 Cr | ₹0.98 Cr |
| Operating Profit | ₹1,503 Cr | ₹1,265 Cr | ₹1,734 Cr | ₹1,437 Cr | ₹1,095 Cr |
| Interest | ₹26 Cr | ₹7.45 Cr | ₹5.24 Cr | ₹3.41 Cr | ₹7.18 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹4.41 Cr | ₹1.16 Cr | ₹1.84 Cr | ₹0.50 Cr | ₹0.93 Cr |
| Other Interest | ₹22 Cr | ₹6.29 Cr | ₹3.40 Cr | ₹2.91 Cr | ₹6.25 Cr |
| PBDT | ₹1,477 Cr | ₹1,258 Cr | ₹1,729 Cr | ₹1,434 Cr | ₹1,087 Cr |
| Depreciation | ₹345 Cr | ₹147 Cr | ₹110 Cr | ₹99 Cr | ₹95 Cr |
| Profit Before Taxation & Exceptional Items | ₹1,133 Cr | ₹1,111 Cr | ₹1,619 Cr | ₹1,335 Cr | ₹993 Cr |
| Exceptional Income / Expenses | - | ₹-56 Cr | - | - | - |
| Profit Before Tax | ₹1,133 Cr | ₹1,055 Cr | ₹1,619 Cr | ₹1,335 Cr | ₹993 Cr |
| Provision for Tax | ₹360 Cr | ₹274 Cr | ₹407 Cr | ₹338 Cr | ₹220 Cr |
| Current Income Tax | ₹349 Cr | ₹277 Cr | ₹396 Cr | ₹339 Cr | ₹251 Cr |
| Deferred Tax | ₹14 Cr | ₹-2.80 Cr | ₹14 Cr | ₹0.12 Cr | ₹-32 Cr |
| Other taxes | ₹-3.55 Cr | ₹-0.82 Cr | ₹-3.00 Cr | ₹-1.72 Cr | ₹0.43 Cr |
| Profit After Tax | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr | ₹773 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr | ₹773 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr | ₹3,026 Cr | ₹2,253 Cr |
| Appropriations | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr | ₹3,026 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | - | - | - | - | - |
| Equity Dividend % | ₹2,000.00 | - | - | - | - |
| Earnings Per Share | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 | ₹49.88 |
| Adjusted EPS | ₹46.90 | ₹47.42 | ₹73.75 | ₹60.94 | ₹49.88 |
Compare Income Statement of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹31,798.2 Cr | 0.6% | -3.2% | 17.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 0.6% |
-3.2% |
17.7% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses